Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tilray (TLRY)
NASDAQ:TLRY
Holding TLRY?
Track your performance easily
TLRY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.14 - $2.97
Previous CloseN/A
Volume22.72M
Average Volume (3M)40.45M
Market Cap
$1.11B
Enterprise Value$1.26B
Total Cash (Recent Filing)$488.47M
Total Debt (Recent Filing)$889.06M
Price to Earnings (P/E)―
Beta1.65
Next Earnings
Apr 15, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding937,655,200
10 Day Avg. Volume45,720,966
30 Day Avg. Volume40,451,159
Standard Deviation0.28
R-Squared0.15
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.36
Price to Cash Flow (P/CF)-7.80
P/FCF Ratio0.00
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue1.52
Enterprise Value/Gross Profit5.65
Enterprise Value/Ebitda-12.38
Forecast
1Y Price Target
$1.68Price Target Upside42.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Tilray News
Bulls Say, Bears Say
Bulls Say
Distribution ExpansionThe company is making progress in ramping up distribution for its acquired beer brands including Shock Top and Montauk.
International GrowthTilray's international businesses are positioned for growth, with expectations for the international cannabis topline to accelerate.
Sales And MarketingIncreased sales and marketing efforts and innovation are expected to improve results.
Bears Say
Financial PerformanceTilray's first quarter revenue and adjusted EBITDA fell short of expectations, highlighting ongoing challenges in the core business due to Canadian price compression.
Market ChallengesCanadian adult-use will be challenging due to price competition.
Regulatory EnvironmentLack of progress in U.S. legislative outcomes is a significant factor affecting Tilray's potential upside.
---
Ownership Overview
0.61% Insiders
0.37% Mutual Funds
0.05% Other Institutional Investors
95.89% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was $1.14 and its highest was $2.97 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $1.11B.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Apr 15, 2025 which is in 87 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Jan 10, 2025. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of -$0.034 by -$0.066.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.04.
How many shares outstanding does Tilray have?
Tilray has 937,655,200 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -$0.1 in its last earnings report, missing expectations of -$0.034. Following the earnings report the stock price went down -10.219%.
Which hedge fund is a major shareholder of Tilray?
Among the largest hedge funds holding Tilray’s share is Highbridge Capital Management LLC. It holds Tilray’s shares valued at 9M.
---
Tilray Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.68 (42.37% Upside)
$1.68 (42.37% Upside)
Blogger Sentiment
Bullish
TLRY Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $35.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 4.4%
Last 30 Days ▲ 4.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.54%
12-Months-Change
Fundamentals
Return on Equity
-7.28%
Trailing 12-Months
Asset Growth
-3.21%
Trailing 12-Months
Company Description
Tilray
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
---
TLRY Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and successful expansion in the beverage and international cannabis segments. However, these positives were tempered by significant net loss and challenges in the Canadian cannabis market, as well as impacts from SKU rationalization. Though there are promising growth areas, the financial setbacks and market challenges balance the overall sentiment.Read More>---
TLRY Stock 12 Month Forecast
Average Price Target
$1.68
▲(42.37% Upside)
Technical Analysis
Aurora Cannabis
―
Cronos Group
―
Canopy Growth
―
OrganiGram Holdings
―
Curaleaf Holdings
―
Pacira Pharmaceuticals
―
Best Analysts Covering TLRY
1 Year
1 Year Success Rate
2/14 ratings generated profit
1 Year Average Return
-40.51%
reiterated a buy rating 4 days ago
Copying Owen Bennett's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -40.51% per trade.
---